Differential gene expression profiles of hepatocellular carcinomas associated or not with viral infection

Brazilian Journal of Medical and Biological Research

Volumn 42, Issue 12, 2009, Pages 1119-1127

  Bellodi Privato, M ^a   Kubrusly, M S ^a   Stefano, J T ^a   Soares, I C ^a   Wakamatsu, A ^a   Oliveira, A C ^a   Alves, V A F ^a   Bacchella, T ^a   Machado, M C C ^a   D'Albuquerque, L A C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hepatocellular carcinoma; Molecular biomarkers; Oligo microarrays; Viral infection

Indexed keywords

ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR 1; CD51 ANTIGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; I KAPPA B KINASE BETA; PEROXIREDOXIN 6; UNCLASSIFIED DRUG; WNT PROTEIN; WNT10B PROTEIN; TUMOR MARKER;

ARTICLE; CLASSIFIER; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; VIRUS HEPATITIS; DNA MICROARRAY; EXPRESSED SEQUENCE TAG; GENETICS; LIVER TUMOR; METHODOLOGY; VIROLOGY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

CARCINOMA, HEPATOCELLULAR; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION PROFILING; HEPATITIS B; HEPATITIS C; HUMANS; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 73349094726     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009001200002     Document Type: Article

References (30)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276.
2. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999; 353: 1253-1257.
3. Anzola M. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat 2004; 11: 383-393.
4. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, Berry DP. Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer 2007; 43: 979-992.
5. Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J, Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002; 21: 2593-2604.
6. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339-346.
7. Tsutsumi T, Suzuki T, Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, et al. Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein. Virology 2002; 304: 415-424.
8. Midorikawa Y, Makuuchi M, Tang W, Aburatani H. Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges. World J Gastroenterol 2007; 13: 1487-1492.
9. Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 2005; 115: 1503-1521.
10. Edwards D. Non-linear normalization and background correction in one-channel cDNA microarray studies. Bioinformatics 2003; 19: 825-833.
11. Cheadle C, Vawter MP, Freed WJ, Becker KG. Analysis of microarray data using Z score transformation. J Mol Diagn 2003; 5: 73-81.
12. Hastie T, Tibshirani R, Friedman J. The elements of statistical learning. New York: Springer-Verlag; 2001.
13. Yeatman TJ. The future of clinical cancer management: one tumor, one chip. Am Surg 2003; 69: 41-44.
14. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999-2009.
15. Murakami Y, Hayashi K, Hirohashi S, Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 1991; 51: 5520-5525.
16. Andrisani OM, Barnabas S. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis (Review). Int J Oncol 1999; 15: 373-379.
17. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001; 61: 2129-2137.
18. Kurokawa Y, Honma K, Takemasa I, Nakamori S, Kita-Matsuo H, Motoori M, et al. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinomas: a new approach to identify novel tumor markers. Int J Oncol 2006; 28: 383-391.
19. Furuta K, Sato S, Yamauchi T, Kakumu S. Changes in intrahepatic gene expression profiles from chronic hepatitis to hepatocellular carcinoma in patients with hepatitis C virus infection. Hepatol Res 2008; 38: 673-682.
20. Koch KS, Maeda S, He G, Karin M, Leffert HL. Targeted deletion of hepatocyte Ikkbeta confers growth advantages. Biochem Biophys Res Commun 2009; 380: 349-354.
21. Schwabe RF, Brenner DA. Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 2006; 290: G583-G589.
22. Servillo G, la Fazia MA, Sassone-Corsi P. Coupling cAMP signaling to transcription in the liver: pivotal role of CREB and CREM. Exp Cell Res 2002; 275: 143-154.
23. Abramovitch R, Tavor E, Jacob-Hirsch J, Zeira E, Amariglio N, Pappo O, et al. A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Res 2004; 64: 1338-1346.
24. Yoshikawa H, Matsubara K, Zhou X, Okamura S, Kubo T, Murase Y, et al. WNT10B functional dualism: beta-catenin/ Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer. Mol Biol Cell 2007; 18: 4292-4303.
25. Yoo DR, Jang YH, Jeon YK, Kim JY, Jeon W, Choi YJ, et al. Proteomic identification of anti-cancer proteins in luteolintreated human hepatoma Huh-7 cells. Cancer Lett 2009; 282: 48-54.
26. Lee SK, Kim MH, Cheong JY, Cho SW, Yang SJ, Kwack K. Integrin alpha V polymorphisms and haplotypes in a Korean population are associated with susceptibility to chronic hepatitis and hepatocellular carcinoma. Liver Int 2009; 29: 187-195.
27. Damdinsuren B, Nagano H, Wada H, Noda T, Natsag J, Marubashi S, et al. Interferon alpha receptors are important for antiproliferative effect of interferon-alpha against human hepatocellular carcinoma cells. Hepatol Res 2007; 37: 77-83.
28. Oie S, Ono M, Yano H, Maruyama Y, Terada T, Yamada Y, et al. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha. Int J Oncol 2006; 29: 1469-1478.
29. Meireles SI, Cristo EB, Carvalho AF, Hirata R Jr, Pelosof A, Gomes LI, et al. Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa. Cancer Res 2004; 64: 1255-1265.
30. Stolf BS, Santos MM, Simao DF, Diaz JP, Cristo EB, Hirata R Jr, et al. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression. Cancer 2006; 106: 1891-1900.